Skip to content
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Menu
Search
Toggle Menu
Change Country
Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
Our COVID-19 Efforts
The Road to a Vaccine
About J&J
Our Credo
Our Leadership Team
Code of Business Conduct
Corporate Reports
Diversity, Equity & Inclusion
ESG Policies & Positions
Innovation at J&J
J&J Health and Wellness Solutions
Office of the Chief Medical Officer
Veterans, Military & Military Families
Products
Consumer Health
MedTech
Pharmaceutical Products
Suppliers
Responsibility Supply Base
Supplier-Enabled Innovation
Supplier Resources
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
2023 Annual Meeting of Shareholders
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2021 Janssen Transparency Report
2021 Health for Humanity Report
ESG Investor Update
ESG Resources
Stock Information
Webcasts & Presentations
Investor Fact Sheet
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Sustainability
Close Countries Menu
Explore more Johnson & Johnson sites:
Australia
Argentina
Brazil
Canada
Consumer Health
Janssen
MedTech
Chile
China
Colombia
Costa Rica
Czech Republic
Ecuador
France
Germany
India
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
United Kingdom
United States
Uruguay
Venezuela
Close Search Menu
Search input
Share
Investor Information
Get the latest news, conference announcements, press releases and company performance information to be an informed shareholder.
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Learn More
Listen to Webcast: Johnson & Johnson at the Barclays Global Healthcare Conference
Listen to Webcast: Johnson & Johnson at the Cowen 43rd Annual HealthCare Conference
Listen to Webcast: Johnson & Johnson at the SVB Securities Global Biopharma Conference
NYSE: JNJ
$155.00
$1.57 (
1.020
%)
Day High
$155.19
Day Low
$153.24
Volume
9,890,047
Last Updated:
3/31/2023 04.10 PM
2023 Annual Meeting of Shareholders
2023 Annual Meeting of Shareholders
Annual Meeting Materials and Webcast
2022 ESG Investor Update Webcast
2022 ESG Investor Update Webcast
Learn More
Latest News Releases
Latest News
March 29, 2023
New RYBREVANT
®
(amivantamab-vmjw) Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy
Financial
March 15, 2023
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Latest News
February 16, 2023
Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
See All News Releases
ON NOW
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
ON NOW
2021 Health for Humanity Report
2021 Health for Humanity Report
2021 Health for Humanity Report
ON NOW
2021 Janssen U.S. Transparency Report
2021 Janssen U.S. Transparency Report
2021 Janssen U.S. Transparency Report
ON NOW
2022 Annual Report
2022 Annual Report
Investor Relations
ON NOW
Corporate Governance
Corporate Governance
Corporate Governance
ON NOW
SEC Filings
SEC Filings
SEC Filings
ON NOW
Pharmaceutical Pipeline
Pharmaceutical Pipeline
Pharmaceutical Pipeline
ON NOW
Stock Information
Stock Information
Stock Information
ON NOW
Webcasts & Presentations
Webcasts & Presentations
Webcasts & Presentations
ON NOW
Investor Fact Sheet
Investor Fact Sheet
Investor Fact Sheet
Quarterly Results
See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.
Learn More
Shareholder Tools
Email Alerts Subscription
RSS News Feeds
Investor FAQs
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Learn More
ESG Resources
Effective management of ESG matters is a business imperative.
Learn More
Contact Investor Relations
Questions? Please contact Investor Relations:
1-800-950-5089
Learn more about our Guidelines for Communication with the Investment Community (Reg FD)
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue